Open live map ×

Unknown location

bit.bio

$25.0M Series D
Announced
Nov 4, 2026
Sector
Biotechnology
Investors
2

Summary

bit.bio secured $25 million in Series D funding to expand its human cell models. bit.bio is a human cell programming company.

Investors

M&G Investments, Jonathan Milner